GET DAILY SIGNALSENTG vs LRCX: Entegris and Lam Research Positioned for AI Growth
Key Takeaways
- Both ENTG and LRCX stand out as semiconductor supply-chain leaders benefiting from AI-driven demand, though they focus on different areas: Entegris provides advanced materials and purification products, while Lam Research supplies wafer fabrication equipment.
- Entegris delivered record revenue above $1 billion and raised its guidance, which triggered a strong rally in recent weeks and pushed its year-to-date gain close to 78%.
- Lam Research also reported record revenue and announced a $25 billion buyback, but its shares declined notably amid supply-chain constraints and a softer outlook for China.
- Relative momentum currently favors ENTG, which trades near its 52-week high, whereas LRCX has pulled back meaningfully from its peak.
- Tickeron AI Verdict: ENTG is the favored ticker of the two, based on stronger trend consistency, stability, and near-term catalysts.
- For additional context, explore ENTG Major News, ENTG Today's Price Move, LRCX Major News, and LRCX Today's Price Move.
- To see how AI models are positioning across the market, explore the Trending AI Robots page.
Why These Two Stocks Matter Right Now
Entegris and Lam Research are two of the most prominent names in the semiconductor supply chain, and both have become focal points for investors tracking the artificial intelligence infrastructure buildout. Although they serve the same industry, their roles differ sharply: Entegris provides the materials, filtration, and purification systems that keep chip fabrication clean and precise, while Lam Research builds the deposition and etch equipment used to manufacture integrated circuits. Comparing these two stocks offers a useful lens on how capital is rotating between materials suppliers and equipment makers in the current cycle, and it is particularly relevant for growth-oriented traders and investors evaluating relative performance, momentum, and market positioning across the semiconductor complex. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.
Entegris: Strong Momentum in Materials
Entegris is a supplier of advanced materials and process solutions for semiconductor and other high-technology manufacturing, operating through its Advanced Purification Solutions (APS) and Materials Solutions (MS) segments. In recent weeks, the company reported record quarterly revenue exceeding $1 billion, up roughly 25% year over year, alongside a sharp improvement in profitability. Adjusted gross margin approached 49%, its highest level in more than 25 years, while adjusted EBITDA margin climbed above 30%.
Management cited rising materials intensity at advanced nodes, double-digit growth across both segments, and a backlog that has more than doubled year over year. The stock responded strongly, with a notable rally following the earnings release and a year-to-date advance near 78%. Sentiment has been further supported by design wins in advanced applications, including EUV filtration, and by an accelerated pace of debt repayment. At the same time, the shares carry a relatively high valuation and an elevated beta, reflecting sensitivity to the broader semiconductor cycle.
Lam Research: Record Results but Some Headwinds
Lam Research designs and manufactures wafer fabrication equipment used to etch, deposit, and clean materials during chip production, with particular strength in memory, foundry, and advanced packaging applications. In its most recent fiscal quarter, the company reported record revenue of $8.22 billion, up 54% year over year and marking a fifth consecutive record quarter. Adjusted EPS of $2.20 narrowly exceeded expectations, while adjusted operating margin crossed 40% for the first time.
Despite these strong results, Lam Research shares fell in the following sessions. Investors weighed management's disclosure of near-term supply-chain constraints that are delaying some shipments, along with an expectation that China's contribution to revenue will decline substantially in the coming quarter. The company also announced a $25 billion share repurchase authorization and generated record free cash flow, underscoring its confidence in long-term AI-driven demand. Even so, the stock has corrected significantly from its highs, and its recent four-week performance has been notably weaker than Entegris's. From what I see, this pullback creates an interesting contrast worth monitoring.
Comparing the Two
The clearest contrast between these two names is where they sit in the semiconductor value chain and how that positioning shapes their risk profiles. Entegris is a materials and consumables supplier whose revenue is tied to wafer production volumes and rising content per chip; its growth tends to be more recurring in nature. Lam Research, by contrast, is a capital-equipment maker whose results are closely linked to cyclical fab equipment spending, known in the industry as WFE.
Momentum also diverges. Entegris has ridden a wave of earnings beats and margin expansion into a strong recent rally, trading near the upper end of its 52-week range. Lam Research, despite a larger absolute revenue base and a higher operating margin, has faced a sentiment reset tied to supply constraints and China exposure, a dynamic that has weighed on its near-term price action. On valuation, Entegris trades at a higher earnings multiple and carries a heavier debt burden relative to its size, though it is actively deleveraging. Lam Research offers a lower earnings multiple, a modest dividend, and an aggressive capital-return program. In terms of risk, Entegris's sensitivity is concentrated in production volumes and execution, while Lam Research's is concentrated in customer capital-spending decisions and geographic concentration. I’m watching this closely as the cycle evolves.
Tickeron AI Verdict
Based on observable factors such as trend consistency, relative momentum, stability, and near-term catalysts, Tickeron's AI would currently favor ENTG over LRCX. Entegris has demonstrated accelerating revenue growth, expanding margins, a doubling backlog, and constructive guidance, all while its shares maintain an upward trend near 52-week highs. Lam Research's fundamentals remain strong, but its recent pullback, supply-chain friction, and China-related uncertainty have introduced greater near-term instability. This assessment reflects a probabilistic read of current conditions rather than a definitive forecast, and it may shift as new earnings, guidance, or macro data emerge.
Exploring Tickeron’s AI Trading Bots
I often turn to Tickeron’s AI Trading Bots when evaluating how automated strategies are handling names like these in the semiconductor space. The platform offers hundreds of bots with different styles, timeframes, and performance profiles, and the AI Trading Bots section lets me quickly review which ones are best suited to current conditions. It has been a practical way to cross-check my own analysis without adding extra layers of complexity.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Momentum Indicator for ENTG turns negative, indicating new downward trend
ENTG saw its Momentum Indicator move below the 0 level on November 04, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 108 similar instances where the indicator turned negative. In 93 of the 108 cases, the stock moved further down in the following days. The odds of a decline are at 86%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for ENTG moved out of overbought territory on October 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 23 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.
The Moving Average Convergence Divergence Histogram (MACD) for ENTG turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 37 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
ENTG moved below its 50-day moving average on November 04, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENTG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for ENTG crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 70%.
Following a +6.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where ENTG advanced for three days, in 194 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
ENTG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 130 of 175 cases where ENTG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. ENTG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 77 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.705) is normal, around the industry mean (5.670). P/E Ratio (63.672) is within average values for comparable stocks, (68.795). Projected Growth (PEG Ratio) (1.312) is also within normal values, averaging (0.801). Dividend Yield (0.003) settles around the average of (0.009) among similar stocks. P/S Ratio (5.984) is also within normal values, averaging (27.897).
The Tickeron Profit vs. Risk Rating rating for this company is 92 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENTG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of critical materials for the semiconductor, data storage, and pharmaceutical industries
Industry ElectronicProductionEquipment
Advertisement